JP2025515098A5 - - Google Patents

Info

Publication number
JP2025515098A5
JP2025515098A5 JP2024564935A JP2024564935A JP2025515098A5 JP 2025515098 A5 JP2025515098 A5 JP 2025515098A5 JP 2024564935 A JP2024564935 A JP 2024564935A JP 2024564935 A JP2024564935 A JP 2024564935A JP 2025515098 A5 JP2025515098 A5 JP 2025515098A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
compound according
formula
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024564935A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025515098A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/066571 external-priority patent/WO2023215803A2/en
Publication of JP2025515098A publication Critical patent/JP2025515098A/ja
Publication of JP2025515098A5 publication Critical patent/JP2025515098A5/ja
Pending legal-status Critical Current

Links

JP2024564935A 2022-05-03 2023-05-03 シトクロムbdオキシダーゼ阻害剤およびその使用 Pending JP2025515098A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263337836P 2022-05-03 2022-05-03
US63/337,836 2022-05-03
PCT/US2023/066571 WO2023215803A2 (en) 2022-05-03 2023-05-03 Cytochrome bd oxidase inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2025515098A JP2025515098A (ja) 2025-05-13
JP2025515098A5 true JP2025515098A5 (cg-RX-API-DMAC7.html) 2026-05-18

Family

ID=88647199

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024564935A Pending JP2025515098A (ja) 2022-05-03 2023-05-03 シトクロムbdオキシダーゼ阻害剤およびその使用

Country Status (4)

Country Link
US (1) US20250282784A1 (cg-RX-API-DMAC7.html)
EP (1) EP4518867A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025515098A (cg-RX-API-DMAC7.html)
WO (1) WO2023215803A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117534677B (zh) * 2024-01-09 2024-03-12 广东省农业科学院农业质量标准与监测技术研究所 一类含亚胺的三环稠合杂环化合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569580B2 (en) * 2004-06-03 2009-08-04 Rigel Pharmaceuticals, Inc. Heterotricyclic compounds for use as HCV inhibitors
CA2599992A1 (en) * 2005-03-03 2006-09-08 Sirtris Pharmaceuticals, Inc. Acridine and quinoline dervatives as sirtuin modulators
WO2007144669A1 (en) * 2006-06-15 2007-12-21 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Pyrazolo[1,5-a]quinazolin-5(4h)-ones as inhibitors of poly(adp-ribose)polymerase (parp)
GB0701273D0 (en) * 2007-01-24 2007-02-28 Angeletti P Ist Richerche Bio New compounds
RU2378278C2 (ru) * 2008-01-24 2010-01-10 Андрей Александрович Иващенко ЗАМЕЩЕННЫЕ 3-СУЛЬФОНИЛ-[1,2,3]ТРИАЗОЛО[1,5-a]ПИРИМИДИНЫ-АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ
WO2009151561A2 (en) * 2008-06-12 2009-12-17 President And Fellows Of Harvard College Methods and compounds for antimicrobial intervention
AU2010295622A1 (en) * 2009-09-16 2012-05-10 Cylene Pharmaceuticals, Inc. Tricyclic compounds and pharmaceutical uses thereof
WO2018084809A1 (en) * 2016-11-02 2018-05-11 Nanyang Technological University Methods for the treatment or prevention of mycobacterial infections
JP7659269B2 (ja) * 2018-12-21 2025-04-09 ユニバーシティ・オブ・ノートル・ダム・デュ・ラック 抗酸菌症治療のためのbdオキシダーゼ阻害剤の発見
CN113354651B (zh) * 2020-07-30 2022-07-22 四川大学 吡唑并[1,5-a]喹唑啉衍生物及其在药物制备中的用途
CN117561258A (zh) * 2021-03-02 2024-02-13 唯久生物技术(苏州)有限公司 作为sos1抑制剂的新型取代的三环氮杂杂环
WO2023287730A1 (en) * 2021-07-13 2023-01-19 Recurium Ip Holdings, Llc Tricyclic compounds

Similar Documents

Publication Publication Date Title
JP2009531322A5 (cg-RX-API-DMAC7.html)
JP2021527126A5 (cg-RX-API-DMAC7.html)
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP2011520815A5 (cg-RX-API-DMAC7.html)
JP2005523922A5 (cg-RX-API-DMAC7.html)
RU2019100164A (ru) Гетероциклическое соединение, используемое как ингибитор fgfr
JP2020507589A5 (cg-RX-API-DMAC7.html)
RU2009102252A (ru) Хиноксалинилмакроциклические ингибиторы серинпротеазы вируса гепатита с
JP2015520769A5 (cg-RX-API-DMAC7.html)
JP2011513305A5 (cg-RX-API-DMAC7.html)
JP2020520955A5 (cg-RX-API-DMAC7.html)
JP2022537140A5 (cg-RX-API-DMAC7.html)
JP2013542992A5 (cg-RX-API-DMAC7.html)
JP2013544276A5 (cg-RX-API-DMAC7.html)
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP2009525287A5 (cg-RX-API-DMAC7.html)
JP2012508249A5 (cg-RX-API-DMAC7.html)
JP2022518741A5 (cg-RX-API-DMAC7.html)
JPWO2023022216A5 (cg-RX-API-DMAC7.html)
JP2008534453A5 (cg-RX-API-DMAC7.html)
JP2016503778A5 (cg-RX-API-DMAC7.html)
JP2020504184A5 (cg-RX-API-DMAC7.html)
AR037852A1 (es) Lactamas como antagonistas de taquiquinina
JP2010520276A5 (cg-RX-API-DMAC7.html)
ECSP22073580A (es) Compuesto de oxazolidinona y métodos de uso de este como agente antibacteriano